This year LKF Central Laboratory, which specialises in international clinical trials, celebrates its 30th anniversary. Although size and services have developed significantly since the beginning, LKF´s corporate philosophy is still the same. With its dedicated team, LKF supports clinical trials with an individual and study-oriented, flexible approach with consistent high-quality laboratory standards.
LKF 30 years dedicated to clinical trials
Sponsored PublicationsThis year LKF Central Laboratory, which specialises in international clinical trials, celebrates its 30th anniversary. Although size and services have developed significantly since the beginning, LKF´s corporate philosophy is still the same. With its dedicated team, LKF supports clinical trials with an individual and study-oriented, flexible approach with consistent high-quality laboratory standards.
Facelift for reusable pipette tip boxes
ProductsThe new box is now called Box 2.0. The new design is a consistent, modern further development of the original product outfit.
Change in Solys BioDyne Management
AppointmentsAt the beginning of September, Stephan Goldenbaum became the new CEO of Estonian Solis BioDyne OÜ. CEO Priit Karjus stepped down to continue the Supervisory Board.
US$21m for microbiome therapies
Latest NewsEnteroBiotix closes an oversubscribed Series A financing with US$21.5m. The biopharma company will use the proceeds to advance its microbiome drug pipeline.
Swiss Biotech Day shows great biopharma ambitions
Latest NewsThe Swiss biopharmaceutical industry is on the verge of record growth: This was demonstrated at the live Swiss Biotech Day in Basel.
Owlstone: US$59m for breath biopsy development
Latest NewsOwlstone Medical has raised US$59m in a Series D financing round. The proceeds will be used to continue development of the company’s breath biopsy tests.
Byondis with new Senior Director
AppointmentsTimo van den Berg is the new senior director Immuno-Oncology Research and Development at Byondis B.V. He joined the company at beginning
EU ends litigation with AstraZeneca
Latest NewsThe EU Commission and AstraZeneca have settled their ongoing legal dispute over the supply of COVID-19 vaccine doses. They agreed to a new delivery schedule.
EuropaBio lobbies for better Orphan Drug rules
Latest NewsEuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.
VectivBio expands rare disease pipeline
Latest NewsSwiss rare disease specialist VectivBio Holding AG is taking over US biotech Comet Therapeutics Inc. for an undisclosed amount. Comet focusses on treatments for metabolic diseases.